geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 35452

Chapter 35452 provides bibliographic information on scholary research in geography and in the life sciences.



P2x7 purinergic receptors exist in the neuron in the monkey retina. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 843 5

P2x7 purinoceptor expression in optic nerve glia in situ. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 255 2

P2x7 receptor induces gene expression. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 338 6

P2x7 receptor mediated erk1/2 phosphorylation in human astrocytoma cells a novel linkage between a ligand gated ion channel and mitogen activated protein kinases. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 338 7

P2y receptors activate the cyclosporin A sensitive transcription factor NFAT in rat vascular smooth muscle cells Influence on interleukin-6 gene induction. FASEB Journal 13(4 PART 1): A47, March 12

P2y2 nucleotide receptor function and distribution in brain tissue and cells. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 142 14

P2y2 nucleotide receptor signaling is modulated by vitronectin receptors in human astrocytoma cells. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 515 1

P2z/p2x7 modulation in experimental Trypanosoma cruzi infection Possible involvement in thymic atrophy and evasion mechanism from macrophages. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 183

P3 and theta frequency shift in rat emerge with acquisition of response habits. European Journal of Neuroscience 12(Supplement 11): 162

P3 response to an acoustic startle probe is modulated by emotional sounds. Psychophysiology 37(Supplement 1): S84, August

P3, Pa/Pb, P4 and P5 Stronger and stronger promoters upstream from blaTEM genes. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 81

P3- -2-oxoethyl ATP for the rapid activation of the Na+,K+-ATPase. Biophysical Journal 79(3): 1346-1357, September

P3-specific amplitude reductions to respiratory and auditory stimuli in asthmatics. Psychophysiology 37(Supplement 1): S102, August

P30 peptides of Toxoplasma gondii. Official Gazette of the United States Patent & Trademark Office Patents 1218(2): 1404, Jan 12

P300 A signature for threat processing in phobic subjects. Psychophysiology 37(Supplement 1): S71, August

P300 ERP variation in a community population Relationship to alcoholism and anxiety disorders. Alcoholism Clinical & Experimental Research 23(5 SUPPL ): 68A, May

P300 abrogates the effects of iron chelation on N-myc expression and apoptosis in human neuroblastoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 15, March

P300 amplitude at age 17 predicts the subsequent development of substance use disorders. Psychophysiology 37(Supplement 1): S66, August

P300 amplitude does not distinguish true from false memories when subjects rate confidence in the Deese paradigm. Psychophysiology 37(Supplement 1): S71, August

P300 and ATF-2 facilitate transcription of c-jun gene during retinoic acid -induced differentiation of embryonal carcinoma cells. Abstracts of Papers American Chemical Society 221(1-2): AGFD 22

P300 and CBP in mouse development and growth control. Biochemical Society Transactions 27(3): A64

P300 and PCAF acetylate GATA-4 in endothelin-1 transcription. Journal of Molecular & Cellular Cardiology 32(11): A107, November

P300 and serum response factor are involved in Rho kinase-mediated c-fos gene expression in cardiac myocytes. Circulation 108(17 Supplement): IV-116, October 28

P300 anterior-posterior slope Effects of task complexity and habituation. Psychophysiology 37(Supplement 1): S89, August

P300 attenuation fails to recover after 31 days of tobacco abstinence. Psychophysiology 37(Supplement 1): S43, August

P300 brain potential in psychiatric genetics A neurobehavioral model of diathesis. American Journal of Medical Genetics 105(7): 630, October 8

P300 cognitve evoked potential and EEG alterations persist after liver transplantation. Journal of Hepatology 36(Supplement 1): 187, April

P300 controls the bcl-2 transcription in association with calcineurin-dependent signaling during myocardial cell survival. Cell Structure & Function 28(4): 371, August

P300 controls the transcription of the bcl-2 gene and associates with calcineurin-dependent signaling during the protection against myocardial cell apoptosis. Circulation 106(19 Supplement): II-236, November 5

P300 event related potential in rats as a function of conditioned reinforcement, primary reinforcement and inhibition of delay during behavioral chains. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 718 13

P300 in androgen-independent prostate cancer From androgen receptor transactivation to cancer progression. Proceedings of the American Association for Cancer Research Annual Meeting 44: 382-383, July

P300 latency in HIV-1 seropositive patients The contribution of premorbid risk factors. Alcoholism Clinical & Experimental Research 27(5 Supplement): 19A, May

P300 mediates Interleukin-6-dependent transactivation of the androgen receptor. Proceedings of the American Association for Cancer Research Annual Meeting 43: 161, March

P300 negatively regulates G0/G1 phase of the cell cycle by repressing c-myc. Proceedings of the American Association for Cancer Research Annual Meeting (41): 562, March

P300 requires Runx2/Cbfa1 and the Vitamin D3 receptor to regulate bone specific osteocalcin expression but not its intrinsic histone acetyl transferase activity. Journal of Bone & Mineral Research 17(Suppl 1): S438-S439, September

P300 scalp distributions in detection of deception. Psychophysiology 37(Supplement 1): S19, August

P300 upregulates the vitamin D-dependent enhancement of the osteocalcin gene transcription in osteoblastic cells. Molecular Biology of the Cell 12(Supplement): 223a, Nov

P300/cAMP-response-element-binding-protein -binding protein modulates co-operation between myocyte enhancer factor 2A and thyroid hormone receptor-retinoid X receptor. Biochemical Journal 369(3): 477-484, 1 February

P301L Tau mutation and non-Alzheimer dementias in Italy. Acta Neurologica Scandinavica 108(5): 379-380

P30L mutation linked to gene conversion in CYP21 gene may cause severe form of CAH. European Journal of Human Genetics 8(Supplement 1): 138, June

P311 and death associated protein 3 Glioblastoma invasion genes identified by laser capture microdissection, differential dysplay, and QRT-PCR. Proceedings of the American Association for Cancer Research Annual Meeting 42: 523-524, March

P311 downregulates TGF-beta1 and TGF-beta2 expression but not TGF-beta3 during myofibroblast transformation. Molecular Biology of the Cell 13(Supplement): 321a, Nov

P311, a small protein with several PEST motifs, plays a role in myofibroblast differentiation. Molecular Biology of the Cell 12(Supplement): 368a-369a, Nov

P32 Mutations in lung cancers from non-smoking women. Proceedings of the American Association for Cancer Research Annual Meeting 40: 279, March

P32 is a general protein kinase C -binding protein Interaction and cellular localization of P32-PKC complexes in rat hepatocytes. Journal of Biological Chemistry 277(7): 5247-5255, February 15

P32/98 Antidiabetic, dipeptidyl-peptidase IV inhibitor. Drugs of the Future 26(9): 859-864, September

P33ING1 involvement in cellular stress response and its in vivo relationship with p53. Journal of Investigative Dermatology 114(4): 854, April

P33ING1 nuclear expression and TP53 gene mutation in colorectal cancer and their association with clinical outcome. Proceedings of the American Association for Cancer Research Annual Meeting 43: 713, March

P33ING1 role in DNA repair. Journal of Investigative Dermatology 117(2): 522, August

P34cdc2 activity indirectly specifies the timing of cytokinesis in echinoderm eggs. Molecular Biology of the Cell 10(SUPPL ): 14a, Nov

P34cdc2 mediated phosphorylation mobilizes MTOCs away from the apical intermediate filament scaffold in CACO-2 epithelial cells. Molecular Biology of the Cell 12(Supplement): 438a, Nov

P35 Cdk5 activator binding protein. Cell Structure & Function 26(5): 486, October

P35 Identification, characterization and functional studies of a novel p53 alternative splice product in the rat. FASEB Journal 13(7): A1480, April 23

P35 proteolysis occurs in a time-dependent manner in a rat model of permanent focal ischemia. Society for Neuroscience Abstracts 27(1): 548

P35-related gene expression in neutrophils as well as monocytes. Immunopharmacology 49(1-2): 11, August

P35/Cdk5 phosphorylates RasGRF2 regulating RasGRF2-mediated Rac signaling and ERK1/2 activity. Journal of Neurochemistry 88(Supplement 1): 81, February

P35NCK5A binding proteins. Official Gazette of the United States Patent & Trademark Office Patents 1283(4), June 22

P3616 A new early human lymphoid marker specific for NK cells lineage differentiation. Blood 94(10 SUPPL 1 PART 1): 463a, Nov 15

P38 Kinase contributes to LPS-induced neurotoxicity in primary midbrain neuron-glia cultures. Society for Neuroscience Abstracts 26(1-2): Abstract No -726 10

P38 MAP KINASE AND CASPASE - 3 MEDIATE Fe2+ - INDUCED NEURONAL DEATH IN CORTICAL CELL CULTURES . Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 292 17

P38 MAP kinase activation by TGF-beta 1 in human proximal tubular cells. Journal of the American Society of Nephrology 14(Abstracts Issue): 90A, November

P38 MAP kinase bidirectionally regulates synaptic plasticity in Aplysia. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 690 3

P38 MAP kinase controls GLUT4 protein levels through regulation of interleukin-6 Evidence for an IL-6 autocrine loop in human adipocytes. Diabetes 52(Supplement 1): A278

P38 MAP kinase inhibition in rheumatoid synovium and ex vivo Effects on cytokine production. FASEB Journal 14(6): A1211, April 20

P38 MAP kinase inhibition induces proliferation through activation of MEK/ERK signaling in the pancreatic cancer cell line, PANC-1. Pancreas 21(4): 438, November

P38 MAP kinase inhibitors. Official Gazette of the United States Patent & Trademark Office Patents 1252(2), Nov 13

P38 MAP kinase inhibitors From biochemical tools to clinical trials. Cellular & Molecular Biology Letters 6(2B): 450-451

p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures. Annals of the New York Academy of Sciences 962: 332-346

P38 MAP kinase is involved in osteoclast differentiation but not in osteoclast activation. Journal of Bone & Mineral Research 16(Suppl 1): S384, September

P38 MAP kinase is necessary for UVB irradiation induced c-fos gene expression in human keratinocytes. Proceedings of the American Association for Cancer Research Annual Meeting 40: 553, March

P38 MAP kinase is required for bone metastasis, but not locally aggressive growth, in a mouse model of metastatic breast cancer. Journal of Bone & Mineral Research 17(Suppl 1): S409, September

P38 MAP kinase is required for transforming growth factor beta-mediated cell adhesion in metastatic prostate cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 22, March

P38 MAP kinase is required for ultraviolet-B irradiation induced activator protein-1 activation in human keratinocytes. Proceedings of the American Association for Cancer Research Annual Meeting (41): 249, March

P38 MAP kinase phosphorylation and apoptosis in pacing-induced heart failure. European Heart Journal 23(Abstract Supplement): 200, August-September

P38 MAP kinase plays a role in anesthetic-induced relaxation in skinned pulmonary arterial strips from newborn rabbits. Biophysical Journal 82(1 Part 2): 423a, January

P38 MAP kinase regulates both differentiation and apoptosis in primary human erythroid cells. Blood 98(11 Part 1): 78a-79a, November 16

P38 MAP kinase regulates negative inotropic effect of HIV gp120 on cardiac myocytes through Troponin I phosphorylation. FASEB Journal 16(4): A570, March 20

P38 MAP kinase regulates the production of type IV collagenase in human hepatic stellate cell line LI90 and hepatic adenocarcinoma cell line SK-HEP-1. Hepatology 34(4 Pt 2): 497A, October

P38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by Ang II in SHR but not in WKY. Hypertension (Baltimore) 36(4): 707, October

p38 MAP kinase regulation of AP-2 binding in TGF-beta1-stimulated chondrogenesis of human trabecular bone-derived cells. Annals of the New York Academy of Sciences 961: 172-177

P38 MAP kinase, but not protein kinase C nor NF-kappaB, is involved in ASK1-induced keratinocyte differentiation. Journal of Dermatological Science 23(3): 202, August

P38 MAP kinase-mediated gene repression during hyperosmotic stress. FASEB Journal 15(5): A850, March 8

p38 MAP kinases: beyond the stress response. Trends in Biochemical Sciences 25(6): 257-260

P38 MAP-kinase An exciting target for the treatment of inflammatory diseases. Inflammation Research 52(Supplement 2): S 89, July

P38 MAP-kinase activation and vascular smooth muscle cell migration following nicotine exposure. FASEB Journal 14(4): A33, March 15

P38 MAP-kinase mediates glucose-dependent transcriptional regulation of osteoclast H+-ATPase expression. Journal of Bone & Mineral Research 17(Suppl 1): S352, September

P38 MAPK SIGNALING PATHWAY IS INVOLVED IN TRANSFORMING GROWTH FACTOR-beta /SMAD3-INDUCED APOPTOSIS. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M925

P38 MAPK activation Trigger or mediator in ischaemic preconditioning ?. Journal of Molecular & Cellular Cardiology 33(6): A70, June

P38 MAPK activation is required for autocrine TNF-alpha-induced Hut-78 cell proliferation. Proceedings of the American Association for Cancer Research Annual Meeting (41): 206, March

P38 MAPK activation is required for tumor necrosis factor-alpha-induced proliferation of human leukemic Mo7e cells. Blood 94(10 SUPPL 1 PART 1): 472a, Nov 15

P38 MAPK and Ca2+-independent PLA2 mediate cytoskeletal reorganization triggered by endothelins in Schwann cells. Journal of Neurochemistry 78(Supplement 1): 29, September

P38 MAPK and HSP27 in ACh-induced contraction of cat esophageal circular smooth muscle. Gastroenterology 120(5 Supplement 1): A 219, April

P38 MAPK and JNK are activated, but do not mediate ajoene-induced apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Supplement 1): R13, March

P38 MAPK and JNK oppositely regulate ANG II-induced apoptosis in human glomerular visceral epithelial cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 293A, September

P38 MAPK and ischemic preconditioning Confounding effects of stabilization time and DMSO. Circulation 104(17 Supplement): II 101, October 23

P38 MAPK expression and phosphorylation in human tissues Modulation by insulin, obesity and type 2 diabetes. Diabetes 52(Supplement 1): A52

P38 MAPK in focal stroke selective inhibitor reduces brain injury and neurological deficits. Society for Neuroscience Abstracts 25(1-2): 1060

P38 MAPK induced G1 cell cycle arrest through up-regulation of p21cip1 in TGF-b-treated human HCCs. Hepatology 38(4 Suppl 1): 572A, October

P38 MAPK inhibition halts hypertensive end organ damage and premature mortality in a rat model of cardiac hypertrophy and dysfunction. European Heart Journal 22(Abstract Supplement): 31, September

P38 MAPK inhibition improves intracardiac haemodynamic parameters and attenuates pathological collagen deposition in a rat model of heart failure post-MI. European Heart Journal 22(Abstract Supplement): 234, September

P38 MAPK inhibitor prevents the development of type-1 diabetes and alleviates hyperglycemia in NOD mice A preliminary report. Diabetes 52(Supplement 1): A126-A127

P38 MAPK is activated by the chemical sensitizer DNFB in a fetal skin dendritic cell line. Journal of Investigative Dermatology 117(4): 1014, October

P38 MAPK is involved in the activation of the caspase cascade in okadaic acid-induced renal cell apoptosis. FASEB Journal 15(4): A80, March 7

P38 MAPK mediated ectodomain shedding-cascades of proHB-EGF. Cell Structure & Function 26(5): 485, October

P38 MAPK mediates acute adenosine preconditioning in the adult rat myocardium. FASEB Journal 18(4-5): Abst 213 9

P38 MAPK mediates the acid-induced transcription of PEPCK in LLC-PK1-FBPase+ cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 48A, September

P38 MAPK modulates cell polarity and trophoblast outgrowth during early murine development. Biology of Reproduction 68(Supplement 1): 337-338

P38 MAPK regulates pro-inflammatory mRNA stability via MAPKAPK2. Cytokine 11(11): 939, Nov

p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 22(7): 637-645

p38 MAPK signalling cascades in inflammatory disease. Molecular Medicine Today 5(10): 439-447

P38 MAPK signals transcriptional activation of iNOS in glia. Society for Neuroscience Abstracts 25(1-2): 1764

P38 MAPK-activation during the infarct-inducing ischemia is essential for the protection of ischemic preconditioning. Circulation 106(19 Supplement): II-193, November 5

P38 MAPK-mediated fibrosis following myocardial infarction is regulated by connective tissue growth factor. Circulation 106(19 Supplement): II-267, November 5

P38 MAPK-mediated gamma globin induction involves altered DNA-protein interactions in an upstream promoter element. Blood 102(11): 515a, November 16

P38 MAPK-mediated signals are crucially involved in osteoclast differentiation. Journal of Pharmacological Sciences 91(Supplement I): 43P

P38 Mitogen-Activated Protein kinase activation by UV rays protects human keratinocytes against cell death. Proceedings of the American Association for Cancer Research Annual Meeting (41): 708, March

P38 Mitogen-activated protein kinase mediates axotomy-induced apoptosis of rat retinal ganglion cells. Society for Neuroscience Abstracts 26(1-2): Abstract No -42 12

P38 activity is required for embryonic skeletal patterning in the sea urchin. Development Growth & Differentiation 43(Supplement): S35, July

P38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human Th2 effector cells. FASEB Journal 13(7): A1473, April 23

p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony. Current Opinion in Genetics & Development 12(1): 92-97

P38 and ICE/caspase-1 inhibitors for the treatment of inflammatory diseases. Inflammation Research 50(Supplement 3): S149, September

P38 and JNK inhibit Fas-mediated caspase-8 activation but differentially regulate type II apoptotic signaling in Jurkat T lymphocytes. Molecular & Cellular Proteomics 2(9): 712, September

P38 and erk1/2coordinate corneal epithelial wound healing by activating migration and proliferation respectively induction of map kinase phosphatase by hgf may regulate erk1/2. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 3816

P38 and p38gamma activation by hypoxia Role in hypoxia-induced proliferation and modulation by the D2 receptor. FASEB Journal 13(5 PART 2): A1091, March 15

P38 induces caspase activation via Bcl-2 independent pathway in 6-hydroxydopamine-induced dopaminergic neuronal cell death. Society for Neuroscience Abstracts 27(2): 2325

P38 inhibition attenuates pro-inflammatory activity of C-reactive protein in human peripheral blood monocytes. Circulation 108(17 Supplement): IV-41, October 28

P38 kinase and ERK are involved oppositely in cadmium-induced genotoxicity and mitotic arrest. Proceedings of the American Association for Cancer Research Annual Meeting (41): 60, March

P38 kinase and its downstream target ATF-2 are involved in the osteoblast osmotic response to elevated extracellular glucose. Journal of Bone & Mineral Research 16(Suppl 1): S374, September

P38 kinase as a tumor suppressor. Proceedings of the American Association for Cancer Research Annual Meeting 43: 153, March

P38 kinase inhibitor suppresses inflammation mediated bone loss in rat streptococcal cell wall arthritis. Scandinavian Journal of Immunology 51(Supplement 1): 84, June

P38 kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cells. Circulation 106(19 Supplement): II-157, November 5

P38 kinase regulates phosphorylation and transactivation of p53 in benzo pyrene-mediated apoptosis of Hepa1c1c7 cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 872, March

P38 map kinase activation contributes to macrophage immune dysfunction in sepsis. FASEB Journal 13(5 PART 2): A1152, March 15

P38 map kinase attenuates phorbol ester-mediated activation of the ERK map kinase cascade in adult rat ventricular myocytes. Biophysical Journal 76(1 PART 2): A294, Jan

P38 map kinase is a key regulator of cytokine and chemokine expression in pancreatic acinar cells. Gastroenterology 118(4 Suppl 2 Part 1): A157, April

p38 map kinase substrate specificity differs greatly for protein and peptide substrates. Archives of Biochemistry and Biophysics 382(2): 310-313

P38 mediates RANKL-induced NF-kappaB activation and osteoclastogenesis. Journal of Bone & Mineral Research 17(Suppl 1): S457, September

P38 mediates apoptosis in hippocampal slices exposed to hyperosmotic stress. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 303 14

P38 mitogen activated protein kinase is required for TGFbeta-mediated fibroblastic transition and cell migration. Proceedings of the American Association for Cancer Research Annual Meeting 43: 153, March

P38 mitogen activated protein kinase modulates chemosensitivity of malignant cholangiocytes. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A101, April

P38 mitogen activated protein kinase signalling is required for human beta-cell differentiation. Diabetologia 44(Supplement 1): A 71, August

P38 mitogen-activated kinase activation precedes cyclic stretch and endothelin induced hypertrophy in cardiomyocytes. Journal of Molecular & Cellular Cardiology 31(6): A69, June

P38 mitogen-activated protein kinase activity is not increased in preconditioned versus control rabbit heart. Circulation 102(18 Supplement): II 211, October 31

P38 mitogen-activated protein kinase and extracellular signal-regulated kinase are required for basic fibroblast growth factor -induced DNA synthesis and migration in metanephric mesenchymal cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 520A, September

P38 mitogen-activated protein kinase as a target for drug discovery. Drugs of the Future 24(12): 1345-1354, Dec

P38 mitogen-activated protein kinase expression and activity in diabetic renal cortex Role of metabolic control. Journal of the American Society of Nephrology 14(Abstracts Issue): 129A, November

P38 mitogen-activated protein kinase inhibition prevents early adverse ventricular remodelling in the immediate post-myocardial infarction setting. European Heart Journal 24(Abstract Supplement): 26, August-September

P38 mitogen-activated protein kinase inhibitor SB203580 attenuate the mechanical allodynia in neuropathic pain model. Journal of Pharmacological Sciences 91(Supplement I): 187P

p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials. Pharmacology & Therapeutics 82(2-3): 389-397

P38 mitogen-activated protein kinase is activated by high glucose. Diabetes 48(SUPPL 1): A68

P38 mitogen-activated protein kinase is activated in the spinal microglia of neuropathic pain model. Japanese Journal of Pharmacology 88(Supplement 1): 82P

P38 mitogen-activated protein kinase is involved in H2O2-induced phospholipase D activation in vascular smooth muscle cells. Park, Sang Chul [Author], Hwang, Eun Seong [Author], Kim, Hyun-Sook [Author], Park, Woong-Yang [Author] Annals of the New York Academy of Sciences Healthy aging for functional longevity: Molecular and cellular interactions in senescence 376

P38 mitogen-activated protein kinase is involved in NMDA-induced retinal ganglion cell death in vivo. Society for Neuroscience Abstracts 27(1): 697

P38 mitogen-activated protein kinase is involved in activin A mediated expression of pro-endocrine gene neurogenin3 in AR42J-B13 cells. Diabetes 52(Supplement 1): A366

P38 mitogen-activated protein kinase is involved in angiotensinogen gene expression stimulated by high levels of glucose in immortalized rat proximal tubular cells. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 466A, Sept

P38 mitogen-activated protein kinase mediates transactivation of epidermal growth factor receptor by oxidative stress in renal epithelial cells. FASEB Journal 18(4-5): Abst 400 10

P38 mitogen-activated protein kinase pathway is involved in urokinase plasminogen activator expression and matrix invasiveness in gastric cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 9, March

P38 mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 499A, September

P38 mitogen-activated protein kinase regulates MMP-2 expression and invasion of malignant melanoma cells. Proceedings of the American Association for Cancer Research Annual Meeting (41): 870, March

P38 mitogen-activated protein kinase regulates low potassium-induced apoptosis in cultured cerebellar granule neurons. Neuroscience Research Supplement (24): S142

P38 mitogen-activated protein kinase response to oxidative stress in two smooth muscle cell types. Journal of Submicroscopic Cytology & Pathology 32(3): 349, July

P38 mitogen-activated protein kinase-mediated fibrosis following myocardial infarction is regulated by connective tissue growth factor. European Heart Journal 24(Abstract Supplement): 554, August-September

P38 mitogen-activated protein kinases in chondrocyte differentiation. Journal of Bone & Mineral Research 17(Suppl 1): S402, September

P38 mitogen-activated protein kinases mediate ultraviolet B -induced COX-2 expression and inflammation in the skin of SKH-1 hairless mice. Journal of Investigative Dermatology 121(1): 0769, July

P38 related/activated kinase translocates from nuclear to peri-nuclear regions just prior to blastocyst formation in the mouse and cow. Biology of Reproduction 64(Supplement 1): 279

P38 stress-activated protein kinase activity is required for the lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. British Journal of Haematology 105(SUPPL 1): 33, April

P38 stress-activated protein kinase and NF-kappaB activity are required for lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. Blood 94(10 SUPPL 1 PART 1): 214a, Nov 15

P38, a subtype of mitogen activated protein kinase is essential for the differentiation of skeletal muscle cells. FASEB Journal 15(5): A1162, March 8

P38-MAPK mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 315A-316A, September

P38-mediated regulation of a FADD-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in the human Burkitt lymphoma B cells BL41. Biology of the Cell (Paris) 93(1-2): 117, September

P38-mitogen activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 45(Supplement 2): A 75, August

P38MAP kinase is proapoptotic in human primary erythroid cells. Experimental Hematology (Charlottesville) 29(8 Supplement 1): 46, August

P38MAPK expression and activation in renal tubulointerstitial fibrosis in rat model of unilateral ureteral obstruction Role of angiotensin II. Journal of the American Society of Nephrology 14(Abstracts Issue): 121A, November

P38MAPK inhibitor and uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1273(1), Aug 5

P38MAPK-activated AKT in erbB-2-overexpressing cells acts as an EGF-independent survival signal. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1186, July

P38alpha MAP kinase regulates morphological changes induced by fluid shear stress. FASEB Journal 14(4): A450, March 15

P38alpha MAPK participates in the signaling pathway for proplatelet formation in murine megakaryocytes. Blood 98(11 Part 1): 794a, November 16

P38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival in response to pressure overload. Circulation 108(17 Supplement): IV-145, October 28

P38gamma MAPK regulation of glucose uptake in L6 myotubes and mouse skeletal muscle. Diabetes 52(Supplement 1): A279

P3A assessment of tobacco smoking in chippers and smokers. Psychophysiology 37(Supplement 1): S45, August

P4 protein of dsRNA bacteriophages is a unidirectional RNA packaging motor. Biophysical Journal 84(2 Part 2): 362a, February

P40 gen amplification in squamous cell lung carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 40: 376, March

P40 protein acts as an oncogene. Official Gazette of the United States Patent & Trademark Office Patents 1264(1), Nov 5

P40-binding proteins. Proceedings of the American Association for Cancer Research Annual Meeting 40: 103, March

P40phox is phosphorylated on T154 and S315 by a protein kinase C-type kinase during NADPH oxidase activation. European Journal of Clinical Investigation 29(SUPPL 1): 41, April

P41 is a cleavage product from oncoprotein SETbeta by caspase in radiation-induced MOLT-4 cell death. Journal of Radiation Research 41(4): 414, December

P42/44 member of the mitogen-activated protein kinase family is activated in left ventricular hypertrophy before the transition towards heart failure in homozygous REN2 rats. European Heart Journal 22(Abstract Supplement): 680, September

P42/44 mitogen activated kinase controls phosphorylation of myosin light chains induced by extracellular ATP in endothelial cells. Circulation 106(19 Supplement): II-150, November 5

P42/44 mitogen-activated protein kinase and reactive oxygen species mediate angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells. Circulation 100(18 SUPPL ): I 430, Nov 2

P42/44 mitogen-activated protein kinase is required for calcitonin-induced 25-hydroxyvitamin D 1alpha-hydroxylase gene expression. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 195A-196A, September

P42/p44 MAP kinases activation is required for insulin secretion in response to physiological glucose concentrations in the MIN6 pancreatic beta cell line. Diabetes 52(Supplement 1): A373

P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1256(2), Mar 12

P44 and p42 MAP kinase enzyme activity is up regulated in Caco-2 cells cultured with Campylobacter jejuni. IJMM International Journal of Medical Microbiology 293(Supplement 35): 68, August

P44 gene expression during the course of SCID mouse and horse infection by Anaplasma phagocytophila. Abstracts of the General Meeting of the American Society for Microbiology 103: D-200

P44/42 MAP kinase directly phosphorylates the CDK-inhibitor p27KIP1 Role in hypertrophy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 623A-624A, September

P44/p42 MAP kinase and transcription factor Egr-1 mediate VEGF induced TF expression by retinal capillary endothelial cells. IOVS 41(4): S870, March 15

P450 CYP2C9 polymorphism in patients on oral anticoagulant treatment. Haemostasis 30(Suppl 1): 106-107, May

P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease. Advances in Neurology 80: 271-286

P450 arachidonic acid epoxides are endogenous neuroprotectants in experimental cerebral ischemia. Society for Neuroscience Abstracts 27(1): 549

P450 enzymes and polymorphism. Journal of Pharmacy & Pharmacology 52(Supplement): 293, September

P450 humanized mice. Toxicology Letters (Shannon) 116(Suppl 1): 7, September 1st

P450 humanized mice Novel animal models for the study of drug and carcinogen metabolism, and the search for endogenous human P450 substrates and functions. Drug Metabolism Reviews 35(Supplement 2): 19

P450 humanized mice for the study of xenobiotics. Drug Metabolism Reviews 35(Supplement 2): 31

P450 humanized mice for the study of xenobiotics CYP3A4 as a paradigm. FASEB Journal 18(4-5): Abst 793 2

P450 inhibition by methylenedioxyphenyl compounds present in goldenseal. Toxicological Sciences 72(S-1): 320, March

P450 polymorphisms and adverse drug reactions. Toxicology 192(1): 55-56, October 1st

P450 reductase Effect on cisplatin/tirapazamine synergy. Proceedings of the American Association for Cancer Research Annual Meeting (41): 765, March

P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metabolism Reviews 31(1): 205-234

P450-mediated metabolism of 1- phenyl-N-. Chemical Research in Toxicology 15(1): 63-75, January

P450-mediated metabolism of capsaicin decreases cytotoxicity to lung and liver cells. Toxicological Sciences 72(S-1): 336-337, March

P450-mediated metabolism of chlorpheniramine in vitro. Clinical Pharmacology & Therapeutics 73(2): P84, February

P4501A1 dependent induction of morphological transformation by benzo pyrene in human lung fibroblast MRC-5V2 cells. Mutation Research 483(Suppl 1): S131, 20 October

P450RGS A cell-based assay for determining dioxin equivalents in environmental samples. Abstracts of Papers American Chemical Society 221(1-2): BIOT 222

P450c17, adrenarche and the polycystic ovary syndrome. Hormone Research (Basel) 51(SUPPL 2): 2, Aug

P450c17-The qualitative regulator of steroidogenesis. Handwerger, S [Editor] Contemporary Endocrinology; Molecular and cellular pediatric endocrinology 139-152

P47 is a cytosolic protein required for in vitro reconstitution of motility of the amoeboid sperm of Ascaris. Molecular Biology of the Cell 10(SUPPL ): 160a, Nov

P47phox association with actin is critical for site-directed activation of NAD H oxidase by Ang II in human vascular smooth muscle cells. Hypertension (Baltimore) 43(6): 1347, June

P50 and memory performance in schizophrenia. Society for Neuroscience Abstracts 25(1-2): 572

P50 ratio and the -2bp deletion of the alpha7 nicotinic acetylcholine receptor. American Journal of Medical Genetics 96(4): 527-528, August 7

P50 sensory gating in high risk adolescents from Palau, Micronesia. American Journal of Medical Genetics 122B(1): 85-86, September 15

P504S A good diagnostic marker for prostate carcinoma. Laboratory Investigation 81(1): 111A, January

P504S A good diagnostic marker for small focus of prostatic adenocarcinoma on needle biopsy. Laboratory Investigation 82(1): 166A, January

P504S antibody expression in putative precursor lesions of prostate carcinoma - high grade prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Modern Pathology 16(1): 152A, January

P504S in diagnosis of prostate cancer A multi-institutional analysis. Laboratory Investigation 82(1): 187A, January

P51 -encoded, secondary trans-activator p51B is also stabilized by genotoxic stress, whose mechanism may not involve MDM2. Proceedings of the American Association for Cancer Research Annual Meeting 43: 985, March

P52Shc is involved in androgen-stimulated proliferation of human prostate cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 546, March

P53 - Dependent apoptosis induced by DNA damage and its relation to ERK signalling in sympathetic neurones. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 147 3

P53 A good diagnostic marker for intratubular germ cell neoplasia. Laboratory Investigation 80(1): 103A, Jan

P53 A possible predictor of response to taxol-based chemotherapy in advanced epithelial ovarian cancers. Gynecologic Oncology 72(3): 507, March

p53: a potential target antigen for immunotherapy of cancer. Annals of the New York Academy of Sciences 910: 223-33; Discussion 233-6

P53 Alterations in primary and metastatic esophageal cancers in a high incidence area of esophageal cancer in northern China. Proceedings of the American Association for Cancer Research Annual Meeting 40: 278, March

P53 And sister chromatid exchange in relation to exposure to pesticides00. Proceedings of the American Association for Cancer Research Annual Meeting 40: 508, March

P53 At the cross-roads of senescence and cancer. Mutagenesis 16(6): 559, November

P53 Basic concepts for cytologists. Acta Cytologica 46(1 Supplement): 225, January-February

P53 Codon 72 polymorphism and HPV infection in low and high grade squamous intraepithelial lesions of the cervix and invasive cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 444, March

P53 Codon 72 polymorphism and lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 248, March

P53 Differentially regulates hypoxia-inducible pro-angiogenic cytokines in malignant glioma. FASEB Journal 17(4-5): Abstract No 406 8, March

P53 Family interactions What implications in human carcinogenesis?. International Journal of Molecular Medicine 8(Supplement 1): S48

p53: fighting cancer. Current Cancer Drug Targets 4(5): 385-402

P53 Gene transfer to the injured rat carotid artery, its role in reducing neointimal formation and apoptosis. FASEB Journal 13(4 PART 1): A129, March 12

P53 Modulate ceramide induced apoptosis in SK-N-SH cell. Society for Neuroscience Abstracts 25(1-2): 570

P53 Mutation analyses support the use of broad histopathologic criteria for the diagnosis of uterine serous carcinoma. Modern Pathology 12(1): 118A, Jan

P53 Mutation analysis and DNA ploidy in bladder wash material. European Urology 36(5): 503, Nov

P53 Polymorphism and HPV16 infection in a Puerto Rican population with head and neck squamous cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 42: 751, March

P53 Polymorphism in HPV related cervical carcinoma Relationship with time to invasion. Modern Pathology 12(1): 115A, Jan

P53 Polymorphisms Do they really influence cervical cancer risk?. Modern Pathology 12(1): 125A, Jan

P53 Requires intact C terminus for G2 delay. Proceedings of the American Association for Cancer Research Annual Meeting 42: 734, March

P53 a prognostic marker in Wilms Tumor. Journal of Urology 171(4 Supplement): 148-149, April

P53 aberrations in B-CLL predict survival and are associated with in-vivo resistance to therapy. Blood 96(11 Part 2): 174b, November 16

P53 abnormalities in stomach cancer by CagA status of Helicobacter pylori infection and histologic type of tumor. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 60

P53 abnormality is not related to atrophic gastritis-gastric cancer pathway induced by Helicobacter pylori infection Study of young Japanese patients. Gastroenterology 116(4 PART 2): A418-A419, April

P53 abnormally in stomach cancer by histological subtype. Proceedings of the American Association for Cancer Research Annual Meeting 40: 243, March

P53 accumulation and p53 mediated transcriptional transactivation in response to ionizing radiation is independent of poly polymerase-1. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1138, March

P53 activates apoptosis of ventricular myocytes independent of de novo gene transcription. Journal of Molecular & Cellular Cardiology 33(6): A100, June

P53 activations abnormalities in CVID patients. FASEB Journal 15(5): A1013, March 8

P53 activity modulates the effect of folate deficiency on genetic damage caused by alkylating agents in human lymphoblastoid cells. Proceedings of the American Association for Cancer Research Annual Meeting (41): 69, March

P53 adenovirus-mediated gene transfer in bladder cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 527, March

P53 allele-specific predisposition in human papillomavirus-associated cervical cancer. Journal of Cancer Research & Clinical Oncology 127(Supplement 1): S22

P53 alteration and chromosomal instability in prostatic high grade intraepithelial neoplasia and concurrent carcinoma Analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of Laser captured microdissected specimens. Laboratory Investigation 82(1): 151A, January

P53 alteration in a population-based study of bladder cancer in New Hampshire. Cancer Epidemiology Biomarkers & Prevention 11(10 Part 2): 1221s, October

p53 alterations in myeloid leukemia. Acta Haematologica 111(1-2): 100-106

P53 analysis in congenital cystic adenomatoid malformation and pleuropulmonary blastoma. Modern Pathology 17(2): 274, February

P53 analysis in urine and blood A new powerful diagnostic tool for bladder cancer?. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1139-1140, March

P53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer or adenomas. Anker, Philippe [Author], Stroun, Maurice [Author] Annals of the New York Academy of Sciences; Circulating nucleic acids in plasma or serum 44-50

P53 and Bcl2 expression in radial growth phase Wistar melanoma cell lines following ultraviolet irradiation. Journal of Investigative Dermatology 119(1): 222, July

P53 and CDKN2a inactivation in primary angiosarcoma of the liver. Pathology Research & Practice 198(3): 185

P53 and CREB cooperativity activates bradykinin B2 receptor gene transcription in renal epithelial cells. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 410A, Sept

P53 and FHIT protein immunohistochemistry in primary gastric adenocarcinoma. Modern Pathology 12(1): 72A, Jan

P53 and Fas/Fas ligand dependent pathways are involved in oxidized low-density lipoprotein -induced apoptosis in vascular smooth muscle cells. FASEB Journal 14(4): A121, March 15

P53 and Her2 neu expression in breast carcinoma occuring in young women. Modern Pathology 16(1): 40A, January

P53 and Hras2 transgenic tumor models working group. Mutation Research 483(Suppl 1): S5, 20 October

P53 and INK4a/ARF genes cooperate in drug-induced apoptosis and senescence in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 43: 834, March

P53 and K-ras gene in colonic lavage and p53 autoantibodies in serum in patients with colonic adenomas. Gastroenterology 118(4 Suppl 2 Part 1): A260, April

P53 and Ki-67 as factors of radioresistance and prognosis in squamous cell carcinoma of head and neck. Laboratory Investigation 80(3): 136A, March

P53 and Ki-67 in non-neoplastic and neoplastic proliferative skin diseases. Virchows Archiv 443(3): 373, September

P53 and MDM2 expression in gastric mucosa with Helicobacter pylori infection. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1393, April

P53 and MIB1 expression in basaloid squamous cell carcinoma of the larynx inversely correlates with p27 expression. Virchows Archiv 443(3): 262-263, September

P53 and P21 Proteins Combined with the International Prognostic Index Can Improve the Prediction of Outcome in Patients with Diffuse Large B-Cell Lymphoma. Blood 100(11): Abstract No 4693, November 16

p53 and TGF-beta in development: prelude to tumor suppression?. Cell 113(3): 275-276

P53 and TNF-alpha regulate a mitochondrial chloride channel protein associated with apoptosis in keratinocytes. Proceedings of the American Association for Cancer Research Annual Meeting 40: 101, March

p53 and ageing: too much of a good thing?. Bioessays 24(7): 577-579

p53 and anti-p53 antibodies as possible markers of a switch towards a neoplastic phenotype in patients infected by Helicobacter pylori. Annals of the New York Academy of Sciences 963: 329-331

P53 and bak mutations in oral cancers associated with betel quid chewing in India. Journal of Radiation Research 44(4): 450-451, December

P53 and bcl-2 expression and chemoresistance in ovarian carcinomas. Virchows Archiv 435(3): 350, Sept

P53 and bcl-2 expression in human cervix cancer cell lines after estradiol treatment. Proceedings of the American Association for Cancer Research Annual Meeting 42: 240, March

P53 and bcl-2 expression in ovarian micropapillary serous tumors. Laboratory Investigation 80(3): 124A, March

P53 and bcl-2 expression in typical and atypical carcinoid tumors of the lung. Pathology Research & Practice 197(5): 312

P53 and beta-catenin in colorectal cancer progression. Current Pharmaceutical Design 9(24): 1932-1936

P53 and c-erbB2 overexpression in microscopic ovarian carcinomas. Laboratory Investigation 81(1): 133A, January

P53 and cell signalling. Radiotherapy & Oncology 56(Supplement 1): S54, September

P53 and drug sensitivity. Proceedings of the American Association for Cancer Research Annual Meeting 40: 771-772, March

P53 and genetic susceptibility to cervix cancer. Gynecologic Oncology 72(3): 461-462, March

P53 and homologues in Barretts adenocarcinoma and precursor lesions The delta-N isoform of p63 a predictor for malignant potential?. Pathology Research & Practice 199(4): 231

P53 and homologues in benign salivary gland tumours The DELTAN isoform of p63 a predictor for malignant potential?. Pathology Research & Practice 199(4): 224-225

P53 and hypoxia mediated gene repression. Proceedings of the American Association for Cancer Research Annual Meeting 42: 702, March

P53 and its homologues p63 and p73 in primary and secondary squamous cell carcinomas of the head and neck. Virchows Archiv 439(3): 245-246, September

P53 and its target genes are essential for chemotherapy-induced hair loss. Journal of Investigative Dermatology 117(2): 428, August

P53 and its tumor-derived mutants Involvement in transcription. International Journal of Molecular Medicine 8(Supplement 1): S75

P53 and ki67 expression of oral squamous cell carcinomas of patients undergoing neoadjuvant radiochemotherapy. Proceedings of the American Association for Cancer Research Annual Meeting 40: 555, March

p53 and matrix metalloproteinases in rheumatoid arthritis: tip of an angiogenic iceberg?. Seminars in Arthritis and Rheumatism 31(5): 287-288

P53 and mdm2 expression in non-small cell lung cancer The lack of prognostic relevance. Pathology Research & Practice 197(5): 333

p53 and neoplastic progression in Barrett's esophagus. American Journal of Gastroenterology 96(5): 1321-1323

P53 and p-glycoprotein expression in primary oropharyngeal SCC. Virchows Archiv 435(3): 173, Sept

P53 and p21 polymorphisms alter in vivo mRNA expression of p21. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1021, March

P53 and p21WAF-1 protein accumulation in cisplatin-sensitive and -resistant ovarian carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting (41): 623, March

P53 and p63 regulate gene expression during renal fibrosis. Journal of the American Society of Nephrology 14(Abstracts Issue): 19A, November

P53 and p73 abnormalities in primary breast carcinoma. International Journal of Molecular Medicine 10(Supplement 1): S42

P53 and pituitary tumour volume and invasiveness. Journal of Endocrinology 160(SUPPL ): P145, March

P53 and ploidy abnormalities in combination are stronger predictors of progression to esophageal adenocarcinoma than either biomarker alone in Barretts esophagus. Cancer Epidemiology Biomarkers & Prevention 12(11 Part 2): 1285s-1286s, November

P53 and progesterone receptor status in meningiomas. British Journal of Cancer 80(SUPPL 2): 34, July

P53 and radiation A rational step towards radiotherapy tailored to molecular prognostic factors. Radiotherapy & Oncology 56(Supplement 1): S54, September

P53 and related proteins in ovarian cancer. British Journal of Cancer 80(SUPPL 2): 72, July

P53 and the decision to die. Journal of Pathology 189(SUPPL ): 28A

P53 and the development of genomic instability Possible role for topoisomerase I interaction. Ehrlich, Melanie DNA alterations in cancer: Genetic and epigenetic changes 409-422

P53 and the integrated response to DNA damage. Smith, Paul J [Author], Jones, Christopher J [Author] Frontiers in Molecular Biology; DNA Recombination and Repair 203-231

P53 antisense agent and method. Official Gazette of the United States Patent & Trademark Office Patents 1257(1), Apr 2

P53 as a mediator of neurotoxicity in Huntingtons disease. Society for Neuroscience Abstracts 27(1): 1507

P53 as a moderator of G2/M arrest after gamma-irradiation of head and neck squamous cell carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 42: 386, March

P53 as a potential predictive factor of response to chemotherapy Feasibility of p53 assessment using a molecular biology functional test in yeast from trucut biopsies in breast cancer patients. European Journal of Cancer 36(Supplement 5): S120, September

P53 as a prognostic predictor in hepatocellular carcinoma. Journal of Hepatology 38(Supplement 2): 96-97, April

P53 as a regulator of cell differentiation. Official Gazette of the United States Patent & Trademark Office Patents 1264(2), Nov 12

P53 as a switch for repression PCAF-mediated acetylation represses G2/M promoters through multiple NF-Y sites. Proceedings of the American Association for Cancer Research Annual Meeting 44: 420, July

p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53. Drug Resistance Updates 5(5): 209-216

P53 as an allosteric system Assays for potential modulators of DNA-binding activity and inhibition by MDM2. Proceedings of the American Association for Cancer Research Annual Meeting (41): 768, March

P53 autoantibodies in patients with non-metastatic invasive breast cancer can be indicative for the development of relapse. Journal of Cancer Research & Clinical Oncology 127(Supplement 1): S22

P53 autoantibodies in serum of patients with colorectal cancer A valuable tumor marker?. European Surgical Research 32(Suppl 1): 7-8, June

P53 becomes transcriptionally active during erythropoietin induced differentiation Identification of p53-regulated genes. Blood 96(11 Part 1): 672a, November 16

P53 binding areas. Official Gazette of the United States Patent & Trademark Office Patents 1285(1), Aug 3

P53 binds and activates the xeroderma pigmentosum p48 gene in humans but not mice. Environmental & Molecular Mutagenesis 39(Supplement 33): 62

P53 caspase independent apoptosis induction by peroxisomicine compound. Proceedings of the American Association for Cancer Research Annual Meeting 40: 580, March

P53 codon 72 Arg single nucleotide polymorphism is associated with prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 44: 460-461, July

P53 codon 72 polymorphism and cancer risk in Li-Fraumeni syndrome. American Journal of Human Genetics 73(5): 471, November

P53 codon 72 polymorphism and its association with advanced lung cancer. International Journal of Molecular Medicine 10(Supplement 1): S94

P53 codon 72 polymorphism and phenotype association in Li-Fraumeni syndrome. Proceedings of the American Association for Cancer Research Annual Meeting 44: 106, July

P53 codon 72 polymorphism and the development of human papilloma virus-associated skin cancer. British Journal of Cancer 80(SUPPL 2): 79, July

P53 codon 72 polymorphism in basal cell carcinoma of skin. EJC Supplements 1(5): S181-S182, September

P53 codon 72 polymorphism in cancer patients in high-risk groups in Poland. International Journal of Cancer Supplement (13): 185

P53 codon 72 polymorphism, response to initial treatment, and risk of relapse in childhood acute lymphoblastic leukemia. Blood 94(10 SUPPL 1 PART 1): 500a, Nov 15

P53 codon 72 polymorphisms and the risk of gastric cancer A hospital-based case-control study. Gastroenterology 120(5 Supplement 1): A 161, April

P53 decreases the phosphorylation of polymerase II by cdk9 A novel mechanism for inhibition of HIV-1 gene expression. Journal of Neurovirology 9(Supplement 3): 98-99

P53 degradation in HPV induced cervical carcinoma occurs before the malignant transformation of dysplastic cells. Modern Pathology 16(1): 180A-181A, January

P53 deletion and fludarabine-resistance in chronic lymphocytic leukaemia. British Journal of Haematology 105(SUPPL 1): 85, April

P53 deletions/mutations in Brazilian adult T-cell leukemia patients. Blood 96(11 Part 2): 229b, November 16

P53 dependent differential expression analysis of etoposide induced stress in the murine small intestine. Gut 52(Supplement 1): A36, April

P53 dependent induction of ISG15 by double-stranded RNA. Journal of Interferon & Cytokine Research 24(Supplement 1): S 116

P53 dependent synergism with co-treatment of head and neck squamous cell carcinoma cells with cisplatin and PI3K specific inhibitor. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1138, March

P53 diagnosis in human cancer What utility?. European Journal of Cancer 37(Supplement 6): S139, October

P53 dysfunction as a cause of the drug resistance and short survival of B-CLL patients with non-hypermutated IgVH genes. British Journal of Haematology 113(Supplement 1): 60, May

P53 enhanced the antitumoral efficacy of E1B 55-Kilodalton mutant adenovirus on hepatocellular carcinoma cell line. Gut 44(SUPPL 1): A87, April

P53 enhances alveolar epithelial differentiation in the fetal human lung through cell-cycle arrest. FASEB Journal 13(4 PART 1): A354, March 12

P53 expression and histopathology in non-invasive and invasive pituitary adenomas and carcinomas. Chinese Medical Journal (English Edition) 113(4): 366, April

P53 expression and mutational status of primary peritoneal micropapillary serous carcinoma with comparison to typical primary peritoneal serous carcinoma. Laboratory Investigation 80(3): 124A, March

P53 expression in colorectal liver metastases does not influence prognosis after partial liver resection. Hepatology 30(4 PART 2): 280A, Oct

P53 expression in gastric cancer cells during chemotherapy induced apoptosis. Journal of Antimicrobial Chemotherapy 44(SUPPL A): 160, July

P53 expression in human proximal tubule-derived cells due to exposition to the nephrotoxin ochratoxin A. Physiological Research 48(SUPPL 1): S119

P53 expression in intraductal breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting (41): 335, March

P53 expression in non small cell lung and small lung carcinomas Relationship with proliferating cell nuclear antigen and cigarette smoking. Virchows Archiv 435(3): 287, Sept

P53 expression in preinvasive cervical squamous intraepithelial neoplasia Has it a story to tell?. Pathology International 50(Supplement): A120, October

P53 expression in prostate cancer and its correlation with microvessel density. Virchows Archiv 443(3): 356-357, September

P53 expression in recurrent gliomas. Pathology International 50(Supplement): A177, October

P53 expression in third trimester human trophoblast under normal and hypoxic conditions. Placenta 21(7): A 21, September

P53 expression in tissue microarray of primary and recurrent gliomas. Brain Pathology 10(4): 575-576, September

P53 expression late in the life cycle of a replication-competent adenovirus improves tumor cell killing and deletion of the death protein improves specificity. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1098, March

P53 family interactions in cancer cells. International Journal of Molecular Medicine 10(Supplement 1): S81

P53 functional status and apoptotic regulation in benign prostatic hyperplasia. Proceedings of the American Association for Cancer Research Annual Meeting (41): 42, March

P53 gene alterations in mouthwash and brush cytology in oral leukoplakia. Journal of Oral Pathology & Medicine 29(7): 357, August

P53 gene family Structural, functional and evolutionary features. Current Genomics 4(1): 13-26, January

P53 gene family p51 -encoded, secondary transactivator p51B occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation. Experimental Cell Research 276(2): 194-200, June 10

P53 gene in simian virus 40-associated non-Hodgkins lymphoma. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1026, July

P53 gene mutation analysis in breast cancer using non-isotopic approach and its clinico-pathologic correlation. International Journal of Cancer Supplement (13): 320

P53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1411, April

P53 gene mutation as a diagnostic approach for esophageal adenocarcinoma. Gastroenterology 118(4 Suppl 2 Part 1): A39, April

P53 gene mutation, microsatellite instability and adjuvant chemotherapy Impact on survival of 494 patients with Dukes C colorectal carcinoma. International Journal of Radiation Oncology Biology Physics 45(3 SUPPL ): 191

P53 gene mutations: case study of a clinical marker for solid tumors. Seminars in Oncology 29(3): 246-257

P53 gene mutations and INK4a-ARF alterations appear to be two mutually exclusive events in hepatocellular carcinomas. Pathology Research & Practice 198(3): 230

P53 gene mutations and P53 protein overexpression The markers of poor prognosis in breast carcinomas. Virchows Archiv 435(3): 336, Sept

P53 gene mutations are a rare event and devoid of prognostic significance in newly diagnosed multiple myeloma patients. Blood 98(11 Part 2): 304b-305b, November 16

P53 gene mutations are associated with poor prognosis in adenocarcinoma of the lung. European Journal of Cancer 35(SUPPL 4): S251, Sept

P53 gene mutations are associated with rapid progression and poor survival in low and low-intermediate risk diffuse large B-cell lymphomas A gela study. Blood 94(10 SUPPL 1 PART 1): 699a, Nov 15

P53 gene mutations in Russian patients with breast cancer detected by chemical cleavage of mismatch. American Journal of Human Genetics 67(4 Supplement 2): 99, October

P53 gene mutations in human esophageal cancer and human esophageal tissues treated with AMN. Mutation Research 483(Suppl 1): S72-S73, 20 October

P53 gene mutations predict poor survival in stage I non-small cell lung cancer Results of a prospective trial. Proceedings of the American Association for Cancer Research Annual Meeting 43: 832, March

p53 gene polymorphism and cancer risk: the debate continues. Clinical Genetics 55(5): 305-306

P53 gene status predicts clinical response of head and neck squamous-cell carcinomas to induction chemotherapy. Virchows Archiv 435(3): 175, Sept

P53 gene therapy for non-small cell lung cancer A preliminary report of phase I trial. Japanese Journal of Pharmacology 82(Suppl 1): 36P

P53 genechip assay, computerized mutation analysis and gene sequencing. European Urology 38(4): 508, October

P53 genotypes, haplotypes and lung cancer susceptibility. International Journal of Molecular Medicine 8(Supplement 1): S71

P53 genotyping is not an effective concept for molecular testing head and neck cancer. American Journal of Human Genetics 65(4): A123, Oct

P53 hemizygosity in pleuropulmonary blastoma A study of fifteen cases. Modern Pathology 17(2): 271, February

P53 hemizygous knockout mice but not APC knockout mice enhance gastric mucosal inflammation induced by H pylori. Gastroenterology. 122(4 Suppl. 1): A-173, Il

P53 immunoexpression in Barretts adenocarcinoma p53 gene mutation vs binding to mdm2 oncoprotein. Laboratory Investigation 82(1): 127A, January

P53 immunohistochemistry and prognosis in bladder cancer Updated results of the ISBC combined analysis. European Urology 36(5): 473, Nov

P53 immunohistochemistry as a prognostic marker in bladder cancer The ISBC combined analysis. Journal of Urology 161(4 SUPPL ): 153, April

P53 immunoreactivity in endometrial cancers developing after radiation treatment for cervical cancer. Modern Pathology 16(1): 206A, January

P53 immunostaining, hTERT and hTR expression in endobronchial premalignant lesions. Proceedings of the American Association for Cancer Research Annual Meeting (41): 536, March

P53 immunostainning is a predictive factor of the presence of metastasis in invasive ductal carcinoma of the breast. Virchows Archiv 439(3): 435, September

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology 57(5): 852-859

P53 in breast carcinomas tested by FASAY reveals better correlations with prognostic variables than p53 immunohistochemistry. Breast Cancer Research & Treatment 57(1): 42

P53 in nasal biopsies of children chronically and sequentially exposed to air pollutants. FASEB Journal 14(4): A173, March 15

P53 in nonneoplastic CNS lesions An immunohistochemical and gene sequencing study. Laboratory Investigation 82(1): 300A, January

p53 in relation to therapeutic outcome of locoregional chemotherapy in pancreatic cancer. Annals of the New York Academy of Sciences 880: 281-287

P53 inactivation under natural selection in brain tumor progression without significant chromosomal instability. Proceedings of the American Association for Cancer Research Annual Meeting (41): 717-718, March

P53 independent radiation induced apoptosis of small intestinal epithelial cells is independent of Fas, TNF and NO. Gastroenterology 116(4 PART 2): A455, April

P53 induces BRCA1 down regulation through specific promoter control in breast cancer. Journal of the American Geriatrics Society 47(9): S48, Sept

P53 influence in tumor responsivenes to cisplatin and oxaliplatin in a transgenic/knock-out mouse tumor model. Proceedings of the American Association for Cancer Research Annual Meeting 40: 95, March

P53 inhibitors and therapeutic use of the same. Official Gazette of the United States Patent & Trademark Office Patents 1272(3), July 15

P53 interferes with HRX fusion protein activation of the p21 promoter. Blood 94(10 SUPPL 1 PART 2): 178b, Nov 15

P53 is a tumor suppressor gene. Cell 116(2 Suppl): S67-9, 1 P Following S69

P53 is associated with cytoplasmic and spindle microtubules and requires functional microtubules for nuclear accumulation. Molecular Biology of the Cell 10(SUPPL ): 430a, Nov

P53 is associated with radioresistance in head and neck carcinomas treated by radical radiotherapy. International Journal of Radiation Oncology Biology Physics 48(3 Supplement): 262

P53 is not required for gamma-tocopheryl quinone to induce apoptosis in cancer cells. FASEB Journal 16(4): A359, March 20

P53 is protective against nitric oxide-induced apoptosis in vascular smooth muscle cells. FASEB Journal 13(5 PART 2): A832, March 15

P53 is resistant to leptomycin B- mediated nuclear accumulation and proteasomal degradation in a subset of neuroblastoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting (41): 622, March

p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis. Carcinogenesis 21(10): 1891-1897

P53 labeling index of biopsy specimens under PTCS is useful in detecting tumor spread of biliary tract carcinomas. Laboratory Investigation 80(3): 188A, March

p53 leans on its siblings. Cancer Cell 1(4): 311-313

P53 mRNA induction after UV irradiation is not modulated by overexpression of deletion-mutant epidermal growth factor receptor in glioblastoma multiforme. Proceedings of the American Association for Cancer Research Annual Meeting 40: 502, March

P53 mRNA levels in PCB-exposed Spisula solidissima embryos. FASEB Journal 13(7): A1433, April 23

P53 mediated apoptosis in human rpe cells after low dose radiation. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 4546

P53 mediates apoptosis in a caspase 8-dependent but FADD-independent manner. Proceedings of the American Association for Cancer Research Annual Meeting (41): 555, March

P53 mediates apoptotic cell death during hair follicle regression. Journal of Investigative Dermatology 117(2): 428, August

P53 mediates apoptotic cell death triggered by cyclosporin A. Immunology Letters 73(2-3): 228, September

P53 mediates doxorubicin-induced cardiac toxicity in mice. Circulation 108(17 Supplement): IV-498, October 28

P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. Journal of the American Society of Nephrology 14(1): 128-138

P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of tumor cells to the cytotoxic and mutagenic effects of cisplatin. Proceedings of the American Association for Cancer Research Annual Meeting 42: 424, March

P53 modulates the effects of loss of DNA mismatch repair on the cytotoxicity and mutagenicity of hydrogen peroxide. Proceedings of the American Association for Cancer Research Annual Meeting (41): 263, March

P53 mutant mice that display early aging-associated phenotypes. Toxicologic Pathology 31(1): 152-153, January-February

P53 mutant protein assay Calibrator preparation and procedure development. Clinical Chemistry 45(6 PART 2): A118, June

P53 mutant protein in serum could be used as breast cancer marker. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1141, March

P53 mutants up-regulate collagenase-3 expression and they are dominant. Arthritis & Rheumatism 42(9 SUPPL ): S201, Sept

P53 mutation analysis in patients with ulcerative colitis in respect to the disease onset. Gastroenterology 116(4 PART 2): A376, April

P53 mutation analysis of breast tumors from a large unselected cohort of BRCA2 mutation carriers and non carriers. American Journal of Human Genetics 69(4 Supplement): 267, October

P53 mutation analysis of resected colorectal liver metastases in relation to immunohistochemistry and prognosis. Hepatology 32(4 Pt 2): 229A, October

P53 mutation and cisplatin sensitivity in laryngeal carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting (41): 690, March

P53 mutation and genetic instability in the early stages of multifocal esophageal squamous cell carcinoma Analysis using micromanipulator-based microdissection and PCR technique. Virchows Archiv 435(3): 293, Sept

P53 mutation associated with the renal granuloma formation in patients with Wegener granulomatosis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 547A, September

P53 mutation detection by multiplex PCR Detection of novel sequence variation in archival ovarian cancer samples. Proceedings of the American Association for Cancer Research Annual Meeting 40: 206, March

P53 mutation does not influence COX-2 immunoreactivity in gastric adenocarcinoma. Gut 50(Supplement 2): A107-A108, April

P53 mutation is one of mechanisms for escape from type-II TGF-beta receptor-mediated growth inhibitory signal in human gastric cancer cells. Gastroenterology 118(4 Suppl 2 Part 1): AGA A553, April

P53 mutation spectrum in iron overload-associated Hepatocellular Carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 42: 351, March

P53 mutation spectrum in non-small cell lung cancer Results from a prospective study. American Journal of Human Genetics 65(4): A312, Oct

P53 mutation status and induction of apoptosis using a novel Bcl-xL inhibitor in head and neck squamous cell carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 44: 332-333, July

P53 mutation, exposure, and genetic susceptibility in a case-control study of bladder cancer. American Journal of Epidemiology 153(11 Supplement): S122, June 1

P53 mutation, p16/CDKN2A deletion, and EWS-FL11 fusion type in Ewing sarcoma An analysis of 60 cases. Modern Pathology 16(1): 14A, January

P53 mutational spectrum in hepatocellular carcinoma associated with hemochromatosis, an iron-overload disease. Proceedings of the American Association for Cancer Research Annual Meeting (41): 234, March

P53 mutational status contributes to Bcl-2 and Bax protein expression levels in squamous cell carcinoma of the head and neck. Proceedings of the American Association for Cancer Research Annual Meeting 42: 225, March

P53 mutations A novel germline aberration and a rare transversion in a supratentorial primitive neuroectodermal tumor Clinical implications. International Journal of Molecular Medicine 12(Supplement 1): S8

P53 mutations An early event in AIDS-associated non Hodgkins lymphomas ?. British Journal of Cancer 83(Supplement 1): 15, July

P53 mutations affect drug sensitivity by altering thymidylate synthase levels rather than apoptotic pathways. International Journal of Molecular Medicine 8(Supplement 1): S80

P53 mutations and PAX5 and SHB genes expression in superficial bladder cancer. European Journal of Human Genetics 10(Supplement 1): 89

P53 mutations and breast cancer established risk factors. American Journal of Epidemiology 153(11 Supplement): S109, June 1

P53 mutations and codon 213 polymorphism in lung cancers of former uranium miners. Proceedings of the American Association for Cancer Research Annual Meeting 40: 244, March

P53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach and its role as a precancerous lesion. Gastroenterology 120(5 Supplement 1): A 299-A 300, April

P53 mutations and over-expression in head and neck cancer. European Archives of Oto-Rhino-Laryngology 257(2): 111, Feb

P53 mutations are early events in the tobacco-associated human lung carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 41: 873, March

P53 mutations as a biomarker in female lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 43: 403, March

P53 mutations at psoralen photochemical hot spots - Rare but significant events in PUVA induced skin cancers. Journal of Investigative Dermatology 112(4): 657, April

P53 mutations do not predict response to paclitaxel in non-small cell lung cancer. Laboratory Investigation 80(3): 213A, March

P53 mutations in Barretts esophagus predict poor response to photodynamic therapy. Gastroenterology 120(5 Supplement 1): A 413, April

P53 mutations in DCIS not associated with invasive breast cancer. Laboratory Investigation 81(1): 25A, January

P53 mutations in UV-induced skin tumors from XPC-deficient mice. Photochemistry & Photobiology 69(SPEC ISSUE ): 3S, June

P53 mutations in basal cell carcinomas arising in routine sunscreen users. Photochemistry & Photobiology 69(SPEC ISSUE ): 33S, June

p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochemistry and Photobiology 70(5): 798-806

P53 mutations in benign breast tissue. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1131, July

P53 mutations in bone marrow stromal cells may play a critical role in leukemia through the induction of angiogenic and lymphangiogenic factors. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1053, March

P53 mutations in gastric cancer in a population of the United States. Proceedings of the American Association for Cancer Research Annual Meeting 42: 224, March

P53 mutations in head and neck cancer of India, and cell growth control in a novel p53 mutant. International Journal of Molecular Medicine 6(Supplement 1): S43

P53 mutations in human urinary bladder cancer. British Journal of Cancer 80(SUPPL 2): 71, July

P53 mutations in murine skin tumors induced by combined ethanol, aloe emodin and UV radiation resemble mutations in human skin cancer. Proceedings of the American Association for Cancer Research Annual Meeting 42: 807, March

P53 mutations in oesopahgeal adenocarcinoma are common and are associated with disease response. Gut 50(Supplement 2): A92, April

P53 mutations in oral smears of patients with squamous cell carcinoma of the oral cavity. Anticancer Research 19(6D): 5676, Nov -Dec

P53 mutations in spontaneous abortions. European Journal of Human Genetics 7(SUPPL 1): 127, July

P53 mutations in sporadic breast cancer Comparative analysis by FAMA and SSCP. Proceedings of the American Association for Cancer Research Annual Meeting 40: 690, March

P53 mutations in the Carolina Breast Cancer Study Spectrum and clinical associations. Proceedings of the American Association for Cancer Research Annual Meeting 40: 194, March

P53 mutations in the gastric mucosa of Helicobacter pylori-positive patients with gastric carcinoma. Gut 49(Supplement 11): A58, September

P53 mutations may explain the decreased survival in the activated B-like subgroup of diffuse large B-cell lymphomas. Laboratory Investigation 82(1): 242A, January

P53 mutations, DNA repair gene polymorphisms, and bladder cancer risk. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1020, March

P53 negatively regulates the human cdk1 expression via NF-Y transcription factor. FASEB Journal 13(7): A1461, April 23

P53 network Its downstream regulated genes. Biochemical Society Transactions 28(5): A227, October

P53 nuclear accumulation is not associated with prolonged disease free survival among patients with node positive transitional cell carcinoma of the bladder. Journal of Urology 163(4 Suppl ): 234-235, April

P53 null mice maintain high levels of AFB1 activating P450s but fail to develop appropriate levels of AFB1 detoxifying GSTs during the first four months of age. Proceedings of the American Association for Cancer Research Annual Meeting 42: 162, March

P53 null mice show impaired GST mediated hepatic detoxification of aflatoxin B1. Proceedings of the American Association for Cancer Research Annual Meeting (41): 839, March

P53 null mutations Further explorations. Proceedings of the American Association for Cancer Research Annual Meeting (41): 276, March

P53 overexpression and angiogenesis in head and neck squamous cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting (41): 687, March

P53 overexpression and cell proliferation index in gastric cancer by anatomic subsite. American Journal of Epidemiology 151(11 Supplement): S77, June 1

P53 overexpression and k-ras mutation in early stage rectal cancer do not correlate with recurrence. Gastroenterology 116(4 PART 2): A379, April

P53 overexpression in metastases of renal cell carcinomas is related to metastatic sites. Journal of Urology 171(4 Supplement): 204, April

p53 overexpression in refractory anemia. An immunohistochemical analysis of bone marrow biopsies. Haematologica 84(4): 377-378

P53 overexpression in transplant patients with skin squamous cell carcinoma. Modern Pathology 16(1): 300A, January

P53 overexpression in vulvar lichen sclerosus does not identify patients at risk for developing a SCC. Modern Pathology 16(1): 94A, January

P53 overexpression is associated with increased risk of malignancy in the megaesophagus but it is not present in megacolon due to Chagas disease. Gastroenterology 118(4 Suppl 2 Part 2): SSAT A1529, April

P53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer. European Journal of Cancer 37(Supplement 6): S118, October

P53 overexpression, epidemiologic risk factors, and early colorectal neoplasia. Proceedings of the American Association for Cancer Research Annual Meeting 42: 35, March

P53 overrides the etoposide-induced G2/M block in K562 cells, leading to enhanced apoptosis. British Journal of Haematology 113(Supplement 1): 25, May

p53 Patches are not increased in patients with multiple nonmelanoma skin cancers. Journal of Investigative Dermatology 117(5): 1324-1325

P53 peptide and small molecule drug regulators of human Rad51. Cancer Gene Therapy 7(12): S7, December

P53 perturbations in endometriosis detected by quantitative real-time PCR Further evidence of late somatic DNA alterations. Fertility & Sterility 80(Suppl 3): S35, September

P53 phosphorylation regulates hypoxia-mediated apoptotic death in tumor cells. Toxicological Sciences 72(S-1): 356, March

P53 plays a significant role in the pathogenesis of Allograft Vasculopathy. Journal of Heart & Lung Transplantation 23(2S): S125, February

P53 polymorphism at codon 72 No evidence for a role in head and neck carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 40: 693, March

P53 polymorphism is a major determinant of treatment outcome in head and neck cancer via its opposing effects on the properties of wild-type and mutant proteins. Proceedings of the American Association for Cancer Research Annual Meeting 44: 382, July

P53 polymorphism of tumor suppressor protein is associated with luminal narrowing after coronary stent placement. Circulation 104(17 Supplement): II 545, October 23

P53 polymorphisms and haplotypes in Jordanian ethnic groups, breast cancer and lung adenocarcinoma patients. Molecular & Cellular Proteomics 2(9): 989, September

P53 possibly upregulates the expression of CD58 and CD59. Medical Hypotheses 58(2): 136-140, February

P53 prevents rapamycin-induced apoptosis in human tumor cells and murine embryo fibroblasts deficient in p53 function. Proceedings of the American Association for Cancer Research Annual Meeting (41): 754, March

P53 profiling of human breast cancer Interactions with smoking. Laboratory Investigation 82(1): 53A, January

P53 promotes neuronal cell death through a nuclear site of action that does not involve a direct effect of p53 at the mitochondria. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 750 4

P53 protects against nitric oxide mediated apoptosis in vascular smooth muscle cells. Acta Physiologica Scandinavica 167(SUPPL 645): 10, Sept

P53 protein and malignant progression in Barretts metaplasia. American Journal of Gastroenterology 98(5): 1200-1201, May

P53 protein and prognosis in Dukes B colorectal cancer. Gastroenterology 116(4 PART 2): A410, April

P53 protein associated with the splicing factor, hnRNP A2, found in mammary cell lysates. Proceedings of the American Association for Cancer Research Annual Meeting 40: 703, March

P53 protein contributed to repair of double strand break. Journal of Radiation Research 41(4): 399, December

P53 protein detection as a diagnostic tool for cancer. FASEB Journal 15(4): A559, March 7

P53 protein expression and proliferative activity in renal cell carcinomas. European Journal of Cancer 35(SUPPL 4): S109, Sept

P53 protein expression and steroid receptors status in primary breast cancer. Clinical Chemistry & Laboratory Medicine 39(Special Supplement): S400

P53 protein expression in Barretts esophagus. Virchows Archiv 435(3): 247, Sept

P53 protein expression in gastric dysplasia and carcinoma. Gastroenterology 116(4 PART 2): A439, April

P53 protein expression in neosquamous mucosa after photodynamic therapy of high grade dysplasia in Barretts esophagus. Gastroenterology 122(4 Suppl 1): A-350, April

P53 protein in esophageal mucosa of individuals at high-risk for squamous cell carcinoma of the esophagus. Gastroenterology 118(4 Suppl 2 Part 1): A36, April

P53 protein levels, cyclin-dependent kinase inhibitor p21, bcl-2 family genes, and caspase-3 activity are altered by cellular zinc status in human aortic endothelial cells. FASEB Journal 15(4): A257, March 7

P53 protein overexpression correlates with increased Ki-67 proliferative activity in urothelial dysplasia of bladder. Laboratory Investigation 82(1): 183A, January

P53 protein overexpression in Shwachman-Diamond syndrome. Archives of Pathology & Laboratory Medicine 126(10): 1157-8; Author Reply 1158

P53 protein overexpression in esophageal and gastric carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting (41): 599, March

P53 protein oxidation in cultured cells in response to PDTC A novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes. Free Radical Biology & Medicine 29(Supplement 1): S59

P53 protein regulates the composition and dynamics of microtubules. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1139, March

P53 protein structural alteration alone does not modify ovarian cancer survival. Proceedings of the American Association for Cancer Research Annual Meeting 44: 700-701, July

P53 protein variants and therapeutic uses thereof. Official Gazette of the United States Patent & Trademark Office Patents 1253(1), Dec 4

P53 proteins in response to DNA damage. Proceedings of the American Association for Cancer Research Annual Meeting 40: 700, March

P53 regulated maspin protein expression determines recurrence-free survival of patients with localized prostate cancer. European Urology 38(4): 491, October

P53 regulates DNA repair after UV radiation. FASEB Journal 15(5): A941, March 8

P53 regulates T cell development through Notch1. FASEB Journal 16(4): A343, March 20

P53 regulates the expression of a novel four transmembrane protein PERP/PIGPC1 in mouse and human prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 42: 218, March

P53 regulates the expression of human hsp90b gene. Biochemical Society Transactions 28(5): A243, October

P53 regulates the response to growth factor deprivation and androgen withdrawal in prostate cancer cells in vitro and in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 42: 229, March

P53 regulates the sensitivity of mouse lung endothelial cells to the DNA-damaging agent, cisplatin. FASEB Journal 18(4-5): Abst 221 7

P53 regulation by Mdm2. Tumor Biology 24(Supplement 1): 2, August

P53 regulation is abnormal in xeroderma pigmentosum group E diploid human fibroblasts. Journal of Investigative Dermatology 121(1): 0134, July

P53 response and function in neuroblastoma cell lines. Biochemical Society Transactions 29(5): A115

P53 responsive DNA elements in the human genome. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1387, July

P53 role in direct surveillance of genome integrity. Toxicologic Pathology 31(1): 159-160, January-February

P53 sequencing in Peyronies disease plaque-derived fibroblasts. Journal of Urology 171(4 Supplement): 381, April

P53 serum antibodies as tumor marker in head and neck cancer. Anticancer Research 22(1B): 534, January-February

P53 signal transduction pathway is not essential for H pylori associated apoptosis and cell growth inhibition in gastric cells. Gastroenterology 116(4 PART 2): A159, April

p53 Signaling and cell cycle checkpoints. Chemical Research in Toxicology 14(3): 243-263

P53 signaling and novel mechanisms for targeted radiosensitizers. EJC Supplements 1(5): S27, September

P53 signaling cascade independent apoptotic induction by zoledronate in BV173, leukemic cell line. Experimental Hematology (New York) 31(7 Supplement 1): 95-96, July

P53 signaling pathway involved in arsenite-induced HOS cell transformation and its prevention by caffeic acid phenethyl ester. Toxicological Sciences 72(S-1): 269, March

P53 stability is regulated by the co-repressor protein mSin3a. Proceedings of the American Association for Cancer Research Annual Meeting (41): 716-717, March

P53 stabilization and functional impairment and frequent deletion of p16INK in uncultured ATLL cells. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 20(4): A15, April 4

P53 stabilization by CP-31398 restores wild type p53-dependent function in ultraviolet B -irradiated murine skin and in A431 cells. Journal of Investigative Dermatology 121(1): 0208, July

P53 stabilizing compound, CP31398, induces apoptosis by activating caspases. Journal of Investigative Dermatology 117(2): 480, August

P53 status and sensitivity to radio- and chemotherapy in 30 cell lines of squamous cell carcinomas of the head and neck. Proceedings of the American Association for Cancer Research Annual Meeting 43: 129, March

P53 status and the expression of cyclin-dependent kinase inhibitors p21waf-1, p16ink4 and p27kip1 in non-Hodgkins lymphomas. Laboratory Investigation. 81(1): 158a, Uary

P53 status and the regression of rectal cancer following preoperative chemoradiotherapy. Gut 46(11): A85, April

P53 status as a determinant of response to arsenic trioxide in human Burkitts lymphoma, prostate and breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting (41): 753, March

P53 status determines nuclear factor-kappaB response in triptolide-induced apoptosis in gastric cancer. Proceedings of the American Association for Cancer Research Annual Meeting 42: 659, March

P53 status determines the cell fate of glioblastoma cells in response to SN-38. Proceedings of the American Association for Cancer Research Annual Meeting 44: 526, July

P53 status predicts recurrence and progression of low stage urothelial carcinoma of the bladder. Journal of Urology 161(4 SUPPL ): 150, April

P53 transactivation photosensitised by the skin phototumorigen lomefloxacin, is not mediated by DNA strand breakage or H2O2. British Journal of Dermatology 144(3): 675, March

P53 transcription activation and BH3 domain - only pro - apoptotic gene expression in neuronal apoptosis after focal cerebral ischemia. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 739 12

P53 triggers mitochondrial cytochrome C release, caspase activation, and apoptosis of ventricular myocytes independent of DNA binding and gene transcription. Canadian Journal of Cardiology 16(Supplement F): 116F, September

P53 tumor suppressor family members can repress transcription of the cdc25C cell cycle phosphatase. Gastroenterology 118(4 Suppl 2 Part 1): A48, April

P53 tumor suppressor gene Its role in DNA damage response and cancer. Dizdaroglu, M , Karakaya, A E NATO ASI Series Series A Life Sciences; Advances in DNA damage and repair: Oxygen radical effects, cellular protection, and biological consequences 371-376

P53 tumor suppressor gene mutations in a spectrum of human cancers in India. Proceedings of the American Association for Cancer Research Annual Meeting 40: 272-273, March

P53 tumor suppressor gene mutations in cancer associated with bacterial and parasitic infections. American Journal of Epidemiology 155(11 Supplement): S27, June 1

P53 tumor suppressor protein. Fisher, David E [Author] Cancer Drug Discovery and Development Tumor suppressor genes in human cancer 159-181

P53 tumor suppressor protein protects renal inner medullary cells from hypertonic stress by restricting DNA replication. FASEB Journal 15(5): A850, March 8

P53, Bcl2, BAX and retinoblastoma gene expression in tumourlets and typical carcinoid tumours of lung. Laboratory Investigation 81(1): 226A, January

P53, HER-2/neu and VEGF determined immunohistochemically in chondrosarcoma. International Journal of Cancer Supplement (13): 274

P53, Ki-67, HER-2/neu, estrogen receptor, and progesterone expression do not predict lymph node metastasis in African American breast cancer patients. Archives of Pathology & Laboratory Medicine 128(2): 149, February

P53, MDM2, and p27 in porokeratosis A unifying pathogenesis?. Modern Pathology 12(1): 61A, Jan

P53, MIB-1, BAX and BCL-2 expression in anal transitional zone dysplasia following ileo-pouch anal anastomosis for inflammatory bowel disease. Gastroenterology 120(5 Supplement 1): A 268, April

P53, RB proteins and microvessel density are long term survival markers in localized carcinoma of the prostate. Journal of Urology 161(4 SUPPL ): 241, April

P53, apoptosis, and chemosensitivity. Hickman, J A [Editor], Dive, C [Editor] Cancer Drug Discovery and Development; Apoptosis and cancer chemotherapy 21-36

P53, apoptotic index and P-glycoprotein as predictive of treatment outcome in Egyptian patients with head and neck squamous cell carcinoma. International Journal of Cancer Supplement (13): 95-96

P53, bcl-2 and BAX immunoreactivity as predictors of response and outcome following chemotherapy for metastatic germ cell testicular tumors. European Urology 38(4): 527, October

P53, bcl-2 and Bax expression in thyroid carcinomas. Virchows Archiv 435(3): 221, Sept

P53, bcl-2 and bcl-w expression in colorectal adenocarcinoma. International Journal of Biological Markers 15(3): 258, July-September

P53, beta-catenin and cyclin D1 are superior to p53 alone in distinguishing problematic uterine serous carcinomas from endometrioid carcinomas. Modern Pathology 16(1): 187A, January

P53, c-Ha-ras and IL-1beta after surgical procedures not inducing hepatocytes proliferation. Journal of Hepatology 32(Supplement 2): 166

P53, c-myc and bcl-2 Expression in gastric carcinomas with and without Epstein-Barr virus infection. Pathology International 50(Supplement): A88, October

P53, gp170 and K 19 as clinical prognostic factors for response in head and neck squamous cell carcinoma. European Journal of Cancer 35(SUPPL 4): S177, Sept

P53, hCHK1, and hCHK2 genes in Finnish families with Li-Fraumeni syndrome; further evidence of hCHK2 in inherited cancer predisposition. European Journal of Human Genetics 9(Supplement 1): P0036

P53, hypoxia and malignant progression. Radiotherapy & Oncology 56(Supplement 1): S53, September

P53, mdm2, p21/waf1, bc12 and bcl-6 proteins expression in non-Hodgkins lymphomas. British Journal of Cancer 85(Supplement 1): 60, July

P53, p21, p27 and bcl-2 as predictors for clinical outcome in rectal cancer. EJC Supplements 1(5): S86, September

P53, pRB and EGFr expression in relation to subtype in the transformation of cervical intraepithelial neoplasia. British Journal of Cancer 86(Supplement 1): S43, June

p53, proto-oncogene and rheumatoid arthritis. Seminars in Arthritis and Rheumatism 31(5): 299-310

P53,cyclin d1 and rb genes expression changes in esophageal squamous cell carcinoma in iran. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1036

P53- and ATM-locus deletions in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes. Blood 102(11): 220b, November 16

P53-LOH in codon 72 of exon 4 in colorectal cancer and liver metastases is associated with preferential loss of the proline allele. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1141-1142, March

P53-Mediated oxidative stress and apoptosis. Toxicologic Pathology 32(1): 163-164, January-February

P53-SSCP-LOH alterations and p53 overexpression in ductal infiltrating carcinoma of breast Correlation with clinicopathological variables. Virchows Archiv 439(3): 439, September

P53-deficiency directly revealed the non-threshold leukemogenesis by a single administration of relatively low-dose of methyl nitrosourea. Experimental Hematology (Charlottesville) 28(7 Supplement 1): 46, July

P53-dependent CD95-mediated apoptosis in primary murine hepatocytes is inducible by interferon-gamma and sensitive to cyclosporin A. Hepatology 32(4 Pt 2): 200A, October

P53-dependent Chk2 expression in gastric cancer, and study on the molecular mechanism. Gastroenterology 122(4 Suppl 1): A-237, April

P53-dependent DNA damage response after ultraviolet B irradiation in skin cells - A useful indicator for UV-induced cellular stress and DNA damage. Journal of Investigative Dermatology 112(4): 657, April

P53-dependent SMC apoptosis induced by mechanical stress is associated with mitochondrial alterations. Circulation 102(18 Supplement): II 240, October 31

P53-dependent and -independent apoptosis of glioma cells. Molecular & Cellular Proteomics 2(9): 920, September

P53-dependent and independent DNA damage responses in primary murine colonocytes A possible functional role for p73alpha. Journal of Pathology 201(Supplement): 6A, September

P53-dependent and independent pathways for G2 arrest in response to DNA damage. Proceedings of the American Association for Cancer Research Annual Meeting 43: 627, March

P53-dependent and p53-independent apoptosis in the mouse lens epithelial cell tumor induced by CPT-11. Proceedings of the American Association for Cancer Research Annual Meeting (41): 300, March

P53-dependent apoptosis induced by heavy-ion beams in human tumors in vivo. International Journal of Radiation Oncology Biology Physics 51(3 Supplement 1): 229-230

p53-dependent apoptosis pathways. Advances in Cancer Research 82: 55-84

P53-dependent ceramide generation in response to ionizing irradiation is caspase-mediated. FASEB Journal 13(7): A1343, April 23

P53-dependent chemosensitivity in melanoma cells. Journal of Investigative Dermatology 112(4): 628, April

P53-dependent cytotoxicity of 5-Fluorouracil and p53-independent cytotoxicity of Tomudex in human colon cancer cells. Gut 44(SUPPL 1): A101, April

P53-dependent gene transcription of the caspase-8 gene after adenovirale infection in human hepatoma cells. Hepatology 36(4 Part 2): 321A, October

P53-dependent induction of Fas expression and augmentation of Fas/FasL-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting (41): 236, March

P53-dependent induction of KILLER/DR5 in cells undergoing apoptosis but not cell cycle arrest. Proceedings of the American Association for Cancer Research Annual Meeting 40: 101, March

P53-dependent induction of WAF1/p21 during PDT-mediated apoptosis and ablation of mouse skin tumors. Photochemistry & Photobiology 69(SPEC ISSUE ): 7S, June

P53-dependent induction of proline oxidase and generation of reactive oxygen species in adriamycin-induced apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 40: 646, March

P53-dependent induction of the TRAIL receptor KILLER/DR5 is conserved in mouse cells and is deficient in cells from patients with ataxia telangiectasia. Proceedings of the American Association for Cancer Research Annual Meeting 40: 434, March

P53-dependent regulation of induction of angiogenic regulatory factors by hyperthermia in vitro. Journal of Radiation Research 44(4): 426, December

P53-dependent transactivation-independent apoptosis in cells carrying temperature-sensitive p53. International Journal of Molecular Medicine 8(Supplement 1): S76

P53-dependent transcriptional regulation of APC gene expression. Proceedings of the American Association for Cancer Research Annual Meeting 42: 219-220, March

P53-independent BRCA1-regulated expression of cellular genes. Proceedings of the American Association for Cancer Research Annual Meeting 40: 694, March

P53-independent apoptototic pathways in testicular germ cell tumor cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 40: 222, March

P53-independent cdk1 induction in response to irinotecan in the HT29 human colon cancer cell line. EJC Supplements 1(5): S289-S290, September

P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin. Molecular Cell Biology Research Communications 3(2): 122-128

P53-independent induction of p21, cell cycle arrest, and the specific targeting of cells endowed with an upregulated DT-diaphorase activity by 3,6-diaziridinyl-1,4-benzoquinone. Free Radical Biology & Medicine 29(Supplement 1): S133

P53-independent mechanism of ARF-mediated activity. Proceedings of the American Association for Cancer Research Annual Meeting 42: 168, March

P53-independent regulation of Mdm-2 transcription in estrogen receptor-positive breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 624, March

P53-independent thermo-chemo-sensitization by NO radical generators in transplanted tumors. Journal of Radiation Research 44(4): 425, December

P53-independent transforming activity of MDM2 alternatively spliced variants and mRNA expression profiles. Proceedings of the American Association for Cancer Research Annual Meeting 42: 223, March

P53-induced apoptosis. Official Gazette of the United States Patent & Trademark Office Patents 1261(2), Aug 13

P53-induced apoptosis and DNA repair. FASEB Journal 13(5 PART 2): A816, March 15

P53-induced apoptosis and new cancer therapy. European Journal of Cancer 37(Supplement 6): S139, October

P53-induced apoptosis is associated with the formation of reactive oxygen species and increased expression of manganese superoxide dismutase. FASEB Journal 13(4 PART 1): A518, March 12

P53-induces neuronal cell death through parallel pathways. Society for Neuroscience Abstracts 27(1): 301

P53-interacting protein Bbp/53BP2 sensitizes cells to doxorubicin-induced apoptosis through stimulation of p53 function. Proceedings of the American Association for Cancer Research Annual Meeting (41): 536, March

P53-mediated apoptosis is compromised by defective binding to altered DNA structure. Proceedings of the American Association for Cancer Research Annual Meeting 44: 658, July

P53-mediated growth arrest in Rb-negative cells. Dizdaroglu, M [Editor], Karakaya, A E [Editor] NATO ASI Series Series A Life Sciences; Advances in DNA damage and repair: Oxygen radical effects, cellular protection, and biological consequences : 477-478

P53-mediated induction of p21/WAF1 and apoptosis during phthalocyanine photodynamic therapy of prostate cancer in transgenic mice. Photochemistry & Photobiology 69(SPEC ISSUE ): 8S, June

P53-mediated phenotypes in the absence of MDM2 versus MDMX. Proceedings of the American Association for Cancer Research Annual Meeting 44: 656-657, July

P53-mediated regulation of expression of a rabbit liver carboxylesterase confers sensitivity to 7-ethyl-10- -1-piperidinocarbonyloxycamptothecin. Journal of Pharmacology & Experimental Therapeutics 304(2): 699-705, February

P53-mediated regulation of proliferating cell nuclear antigen gene expression during kidney development. Pediatric Research 49(4 Part 2): 419A, April

P53-overexpression and polarographically measured tumor-pO2 in squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology Biology Physics 48(3 Supplement): 280-281

P53-overexpression in renal cell carcinoma is associated with histological subtypes. Journal of Urology 169(4 Supplement): 199, April

P53-positive cells in the gastric mucosa before and after Helicobacter pylori eradication. Gastroenterology 118(4 Suppl 2 Part 1): AGA A751, April

P53-positive gastric cancer is infrequently associated with p53-positive intestinal metaplasia. Gastroenterology 116(4 PART 2): A452, April

P53-regulated genes. Official Gazette of the United States Patent & Trademark Office Patents 1231(1), Feb 1

P53-regulated induction of O6-alkylguanine-DNA-alkyltransferase in response to DNA damage. Proceedings of the American Association for Cancer Research Annual Meeting 40: 740, March

P53-regulated selectively attenuated oncolytic adenovirus vectors. Proceedings of the American Association for Cancer Research Annual Meeting 42: 32, March

P53-regulated selectively replicating adenovirus vectors. Cancer Gene Therapy 7(12): S9, December

P53-regulated transcriptional program implicated in genotoxic stress-induced apoptosis. Analytical Cellular Pathology 25(5-6): 262

P53-specific T cell receptor for adoptive immunotherapy. Official Gazette of the United States Patent & Trademark Office Patents 1285(1), Aug 3

P53/DNA-PK-dependent Fenretinide-induced apoptosis in normal and malignant human ovarian surface epithelial cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 458, March

P53/FGFR3 mutations characterize two different molecular pathways at initial diagnosis in transitional cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 44: 99, July

P53/MDM2 interaction and prognosis in medulloblastoma. Tumori 86(4 Suppl 1): 30-31, July-August

P53/MDM2 pathway aberrations in parathyroid pathology p21WAF1 and MDM2 are frequently upregulated in parathyroid adenomas. Virchows Archiv 435(3): 221, Sept

P53/p16 analysis in Brazilian adult t-cell leukemia patients. International Journal of Cancer Supplement (13): 392

P53/p21 immunophenotype predicts for resistance to single-agent platinum in ovarian cancer . British Journal of Cancer 80(SUPPL 2): 72, July

P53AIP1, a potential mediator of p53-dependent apoptosis Its regulation by Ser-46-phosphorylated p53 and interaction with bcl-2 at mitochondria. Proceedings of the American Association for Cancer Research Annual Meeting 42: 419, March

P53Gene Deletion as a Prognostic Factor in Multiple Myeloma. Blood 100(11): Abstract No 5079, November 16

P53Pro72Arg polymorphism is associated with albuminuria among Aboriginal Australians. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 557A, September

P53R2 gene expression modulates growth effects of gemcitabine in head and neck cancer cells following radiation. International Journal of Radiation Oncology Biology Physics 57(2 Supplement): S349

P53RDL1UNC5B as a positive and negative regulator of p53-dependent apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 44: 657, July

P54s6k and p85s6k genes, proteins, primers, probes, and detection methods. Official Gazette of the United States Patent & Trademark Office Patents 1257(3), Apr 16

P55 from Mycobacterium tuberculosis is an antibiotic efflux pump. Abstracts of the General Meeting of the American Society for Microbiology 100: 642

P55CDC mutant induces G1 arrest in nocodazole-treated cells. Molecular Biology of the Cell 12(Supplement): 278a-279a, Nov

P55CDC overexpressing results in premature cell cycle transition from G1 to S phase. Journal of Investigative Medicine 47(2): 61A, Feb

P560, a novel and highly conserved AAA protein related to dynein, is required for viability. Molecular Biology of the Cell 12(Supplement): 448a-449a, Nov

P56lck controls phosphorylation of filamin and regulates focal adhesion kinase. Cell Biology International 26(6): 567-571

P56lck protein tyrosine kinase is required for coxsackievirus B3 activation of the growth-stimulated MAPK signal transduction pathway. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 256-257

P57KIP2 and E2F1 expression in differentiating cultured human lens epithelial cells. IOVS 42(4): S310, March 15

P57KIP2 mutations associated with loss of IGF2 imprinting in Beckwith-Wiedemann syndrome. American Journal of Human Genetics 67(4 Supplement 2): 392, October

P57Kip2, and p107 and p130, regulate chondrocyte proliferation in vivo, and may be targets of PTHrP action. Journal of Bone & Mineral Research 16(Suppl 1): S161, September

P57kip2 a maternally imprinted cdk inhibitor, a useful marker for separating complete mole from other gestations with changes suggestive of molar pregnancy/chromosomal abnormalities. Laboratory Investigation 82(1): 206A-207A, January

P57kip2 is pivotal factor in compensatory tubular cell hypertrophy. Journal of the American Society of Nephrology 14(Abstracts Issue): 328A, November

P58IPK, a potential virulence factor that regulates influenza viral protein synthesis. Biophysical Journal 86(1): 89a, January

P59OASL, an interferon induced 2-5 oligoadenylate synthetase-like protein. Journal of Interferon & Cytokine Research 19(SUPPL 1): S150, Sept

P6 Acpupoint Injection A Prophylactic Treatment for PONV in Children. Anesthesiology Abstracts of Scientific Papers Annual Meeting (2001): Abstract No A-1227

P60 sEGFR/ErbB1, a novel isoform of the human EGFR, functions as a matricellular protein. Proceedings of the American Association for Cancer Research Annual Meeting 43: 331, March

P60 sErbB1 negatively regulates epidermal growth factor receptor signaling. Proceedings of the American Association for Cancer Research Annual Meeting 42: 958, March

P60 sErbB1/EGFR transgenic mice are lactation defective and exhibit altered mammary gland morphology. Molecular Biology of the Cell 11(Supplement): 62a-63a, Dec

P60-src and p125-FAK are potential mediators of PI 3-kinase activation by glycine-extended gastrin precursors. Gastroenterology 118(4 Suppl 2 Part 1): AGA A437, April

P62 interacts with prostate apoptosis response-4 and forms ternary complex with protein kinase C-zeta. FASEB Journal 15(4): A10, March 7

P62 polypeptides, related polypeptides, and uses therefor. Official Gazette of the United States Patent & Trademark Office Patents 1250(3), Sep 18

P62 sequesters multi-ubiquitin conjugated proteins from the cytoplasm. Molecular Biology of the Cell 10(SUPPL ): 297a, Nov

P62/A170 A novel component of Mallory Bodies associated with alcoholic hepatitis. Hepatology 30(4 PART 2): 551A, Oct

P62/ZIP plays a role in regulation of NGF-mediated NF-kappaB activation. FASEB Journal 15(5): A1163, March 8

P62dok and p56dok-2 oppose leukemogenesis by p210Bcr-Abl. Blood 102(11): 650a-651a, November 16

P63 A p53 homologue that is a differentiation-specific marker in cervical squamous epithelium. Modern Pathology 12(1): 178A, Jan

P63 Expression in Response to Phorbol Ester Stimulation in Human Limbal Epithelial Cells Expanded on Intact Human Amniotic Membrane. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1628

P63 a relative of p53-from a general and oral aspect. International Journal of Molecular Medicine 12(Supplement 1): S8

P63 and TTF-1 immunostaining A valuable marker panel for distinguishing small cell carcinoma from poorly differentiated squamous cell carcinoma of lung. Laboratory Investigation 82(1): 330A, January

p63 and p73: old members of a new family. Biochimica et Biophysica Acta 1470(3): M93-M100

P63 expression in human high grade lymphomas. Proceedings of the American Association for Cancer Research Annual Meeting 42: 334, March

P63 expression in label retaining human limbal epithelial cells expanded on intact human amniotic membrane. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1355